Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Pigott

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Biological Psychiatry|January 1, 1993
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPPT A Pigott, J L Hill, T A Grady, et al.
The American Journal of Psychiatry|November 1, 1991
Symptoms of eating disorders in patients with obsessive-compulsive disorderT A Pigott, M Altemus, C S Rubenstein, et al.
Psychiatry Research|October 1, 1993
Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot studyM A Demitrack, F W Putnam, D R Rubinow, et al.
Psychopharmacology Bulletin|January 1, 1989
Neurohypophyseal dysfunction: implications for the pathophysiology of eating disordersM A Demitrack, M D Lesem, H A Brandt, et al.
Journal of Clinical Psychopharmacology|August 1, 1991
A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorderT A Pigott, M T Pato, F L'Heureux, et al.
Archives of General Psychiatry|October 1, 1990
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological resultsT A Pigott, M T Pato, S E Bernstein, et al.
Biological Psychiatry|March 1, 1991
Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorderT A Pigott, J Zohar, J L Hill, et al.
Psychopharmacology|March 1, 1997
Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatmentA Broocks, N C Briggs, T A Pigott, et al.
The Journal of Clinical Psychiatry|April 7, 1999
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive DisorderM L Crismon, M Trivedi, T A Pigott, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biological Psychiatry|January 1, 1993
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPPT A Pigott, J L Hill, T A Grady, et al.
The American Journal of Psychiatry|November 1, 1991
Symptoms of eating disorders in patients with obsessive-compulsive disorderT A Pigott, M Altemus, C S Rubenstein, et al.
Psychiatry Research|October 1, 1993
Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot studyM A Demitrack, F W Putnam, D R Rubinow, et al.
Psychopharmacology Bulletin|January 1, 1989
Neurohypophyseal dysfunction: implications for the pathophysiology of eating disordersM A Demitrack, M D Lesem, H A Brandt, et al.
Journal of Clinical Psychopharmacology|August 1, 1991
A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorderT A Pigott, M T Pato, F L'Heureux, et al.
Archives of General Psychiatry|October 1, 1990
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological resultsT A Pigott, M T Pato, S E Bernstein, et al.
Biological Psychiatry|March 1, 1991
Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorderT A Pigott, J Zohar, J L Hill, et al.
Psychopharmacology|March 1, 1997
Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatmentA Broocks, N C Briggs, T A Pigott, et al.
The Journal of Clinical Psychiatry|April 7, 1999
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive DisorderM L Crismon, M Trivedi, T A Pigott, et al.
Pageof 4